Evolution Research Group, a clinical research site business serving pharmaceutical companies and CROs, has appointed Davide Molho as president and CEO. Previously, he was president and chief operating officer Charles River Laboratories. ERG is backed by Linden Capital Partners.
Keensight Capital hires former Meta data science executive as head of AI
5 hours ago · 2 mins read
Falfurrias hires Great Hill’s Greg Stewart to help lead tech, services deals
3 November 2026 · 1 min read
EIV’s Kristin Kelly: From aspiring vet to energy investor
3 November 2026 · 5 mins read
Permira hires former S&P Global CEO Douglas Peterson as senior adviser
2 November 2026 · 2 mins read
o15 Capital Partners hires Capital One’s Rochelle Probst as managing director
29 October 2026 · 1 min read
HighPost Capital hires Quail Ridge founder Ron Sylvestri as managing director, marketing
28 October 2026 · 1 min read
Broad Sky Partners hires ex-Partners Group investor Henry Elefter as managing director
28 October 2026 · 2 mins read
